Skip to main content
. Author manuscript; available in PMC: 2024 May 22.
Published in final edited form as: Exp Mol Pathol. 2017 May 25;102(3):515–521. doi: 10.1016/j.yexmp.2017.05.015

Figure 1. 1,25 (OH)2D3 ameliorates clinical signs of EAE and suppresses inflammation and demyelination in the CNS.

Figure 1.

(A) Clinical EAE scores were evaluated daily according to a 0-5 severity scale in 1,25(OH)2D3 treated and vehicle mice. Spinal cords were harvested at day 30 p.i. and stained with (B) H&E for inflammation and (C) Luxol fast blue (LFB) (for degree of demyelination. Scale bars= 20 μm. Data represent mean± SEM (n=5/group). *P<0.05. One representative of three independent experiments is shown.